A suspected plague death in Russia has renewed attention on the rare infection. Here's how to spot pneumonic plague, and which antibiotics the CDC recommends.
Commentary|Articles|July 15, 2026
Expert Q&A: What the MMRV Vaccine Equity Data Mean for Pharmacists
Fact checked by: Ron Panarotti
An expert discusses a JAMA study that shows who depends on the MMRV combination vaccine and how policy shifts may widen gaps—plus how pharmacists keep children on schedule.
Advertisement
Advertisement
As debate continues over the Advisory Committee on Immunization Practices' (ACIP) September 2025 vote to stop recommending the combined measles, mumps, rubella, and varicella (MMRV) vaccine for children younger than 4 years—a decision stayed by a US District Court ruling in AAP v Kennedy as of March 16, 2026—a new
Related to this article
Despite the controversy surrounding mRNA's role in the COVID-19 response, the technology's broader promise—to prevent, treat, and even cure a host of diseases—is coming into focus.
Age is the leading factor in influenza vaccine selection, and vaccination remains effective well beyond the ideal September-to-October window.
Emergency and ICU pharmacists would be most likely to see pneumonic plague. An expert reviews first-line agents, alternatives, and postexposure prophylaxis.
The FDA approval of pritelivir offers an oral treatment for refractory HSV lesions in immunocompromised adults, with drug interactions creating an important role for pharmacists.
The first AHA endocarditis update in 11 years expands outpatient options, with a bigger role for pharmacists.
Pharmacists can address patient fears about fentanyl by distinguishing illicit from prescribed opioids and promoting safe, empathetic, evidence-based opioid use.
Each October, the pharmacy profession pauses to recognize technicians' decades-long evolution, from on-the-job trainees to nationally certified health care professionals.
Advertisement
Advertisement